Anixa Biosciences Inc — Director's Dealing 2013

Jul 16, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: COPYTELE INC (COPY)
CIK: 0000715446
Period of Report: 2013-07-01

Reporting Person: BERMAN ROBERT ANDREW (Director, President and CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2013-07-01	Common Stock	J	3447	$0.2901	Acquired	6786	Direct

Footnotes

F1: Shares of Common Stock issued in lieu of an interest payment at the option of the Company.